SIGN UPLog In

General

Financials

People

Founders
Employee Profiles

Activity

Recent News

Last deal

$20M

Amount

Post-IPO Equity

Stage

07.09.2021

Date

3

all rounds

$64.1M

Total amount

date founded

Financing round

General

About Company
Hancock Jaffe Laboratories develops tissue-based solutions for patients with peripheral vascular and end-stage renal disease.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.1987

founders

Number of employees

1-10

Company Type

For Profit

Last funding type

Post-IPO Equity

IPO status

Private

Description

The company's ProCol vascular bioprosthesis, made from a bovine mesenteric vein, has been proven effective in clinical studies for patients with end-stage renal disease. Hancock Jaffe Laboratories focuses on developing bioprosthetic devices and technologies to improve outcomes for patients with cardiovascular diseases, aiming to simplify procedures and deliver efficient healthcare. Founded in 1987, the company is headquartered in Irvine, California.
Contacts

location

Irvine, CA, USA

Phone number

Website URL

http://www.hancockjaffe.com/

Social url

Similar Companies
1000
Healionics
HealionicsHealionics develops a synthetic vascular graft that remains open to blood flow long-term without costly interventions.
Healionics

Healionics

Healionics develops a synthetic vascular graft that remains open to blood flow long-term without costly interventions.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Keywords

Health Care, Medical Device, Biotechnology

Location

Seattle, WA, USA

total rounds

13

total raised

$24.95M
CardioDex
CardioDexCardioDex develops disposable solutions for arterial closure after catheterization procedures.
CardioDex

CardioDex

CardioDex develops disposable solutions for arterial closure after catheterization procedures.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Location

Caesarea, Israel
HemoSonics
HemoSonicsHemoSonics is a medical device company that brings innovative in vitro diagnostics to market to characterize hemostasis.
HemoSonics

HemoSonics

HemoSonics is a medical device company that brings innovative in vitro diagnostics to market to characterize hemostasis.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Keywords

Health Care, Medical Device, Biotechnology

Location

Charlottesville, VA, USA

total rounds

3

total raised

$17.29M
Anuncia Medical
Anuncia MedicalAnuncia Medical's noninvasive device prevents shunt failure and revision brain surgery in patients with hydrocephalus and CSF disorders.
Anuncia Medical

Anuncia Medical

Anuncia Medical's noninvasive device prevents shunt failure and revision brain surgery in patients with hydrocephalus and CSF disorders.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Keywords

Health Care, Medical, Medical Device

Location

Scottsdale, AZ, USA

total rounds

3

total raised

$19K

Financials

Funding Rounds
3
3

Number of Funding Rounds

$64.1M

Money Raised

Their latest funding was raised on 07.09.2021. Their latest investor Perceptive Advisors. Their latest round Post-IPO Equity

Date 
Funding Round 
Investors 
Money Raised 
Lead 
07.09.2021
Post-IPO Equity
1
$20M
Perceptive Advisors
Perceptive Advisors
09.02.2021
Post-IPO Equity
—
$41.4M
—
03.05.2019
Post-IPO Equity
—
$2.7M
—
Perceptive Advisors

Perceptive Advisors

Perceptive Advisors is a privately owned hedge fund sponsor that finances global public equity markets.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Financial Services, Finance, Venture Capital

Location

New York, NY, USA

count Of Investments

256

count Of Exists

20
Co-Investors
Investors
1
1

Number of lead investors

1

Number of investors

Investor 
Lead 
Round 
Partners 
Perceptive Advisors
Perceptive Advisors
Yes
Post-IPO Equity
—
Perceptive Advisors

Perceptive Advisors

Perceptive Advisors is a privately owned hedge fund sponsor that finances global public equity markets.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Financial Services, Finance, Venture Capital

Location

New York, NY, USA

count Of Investments

256

count Of Exists

20

People

Founders
1

Norman Jaffe

Norman Jaffe serves as a founder at Hancock Jaffe Laboratories.

organization founded

1
Norman Jaffe

Norman Jaffe

Employee Profiles
5
Chris Sarner

Chris Sarner

Vice president of regulatory affairs and quality assurance

Vice president of regulatory affairs and quality assurance

Robert Berman
Robert Berman

Robert Berman

CEO

CEO

Marc Glickman
Marc Glickman

Marc Glickman

Senior Vice President and Chief Medical Officer

Senior Vice President and Chief Medical Officer

Craig Glynn
Craig Glynn

Craig Glynn

Interim Chief Financial Officer

Interim Chief Financial Officer

Brian Roselauf
Brian Roselauf

Brian Roselauf

Director of Research and Development

Director of Research and Development

Activity

Recent News
0